
|Slideshows|August 5, 2016
Spotlight on New Oncology Drugs: Access, Costs, and Use
Author(s)Cancer Network Editors
Read compelling analyses of 5-year trends and projected changes in the oncology clinical drug pipeline, selected from the IMS Institute for Healthcare Informatics’ recent “Global Oncology Trend Report.”
Advertisement
Slides republished with permission from the IMS Institute for Healthcare Informatics. Visit theimsinstitute.org to view the full publication, “Global Oncology Trend Report: A Review of 2015 and Outlook to 2020.”
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Daraxonrasib in Pretreated Metastatic Pancreatic Cancer
2
Weighing Bispecific Antibodies Against CAR T-Cell Therapy in Follicular Lymphoma
3
Teclistamab Combos Improve PFS, OS in Relapsed/Refractory Multiple Myeloma
4
Talazoparib/Enzalutamide sNDA Receives FDA Priority Review in HRR+ CSPC
5
























































